Average Co-Inventor Count = 7.42
ph-index = 7
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Incyte Corporation (21 from 665 patents)
2. Incyte Holdings Corporation (7 from 147 patents)
3. Bristol-myers Squibb Compnay (2 from 3,681 patents)
4. Bristol-myers Squibb Pharma Company (1 from 234 patents)
24 patents:
1. 12428426 - Process and intermediates for preparing a JAK1 inhibitor
2. 12247030 - Process for preparing compositions comprising an enantiomeric excess of a substituted pyrrolo[2,3-d]pyrimidine
3. 12071439 - Process and intermediates for preparing a JAK inhibitor
4. 12024522 - Salts and processes of preparing a PI3K inhibitor
5. 11905292 - Process and intermediates for preparing a JAK inhibitor
6. 11897889 - Process and intermediates for preparing a JAK1 inhibitor
7. 11753406 - Salts of a PD-1/PD-L1 inhibitor
8. 11084822 - Salts and processes of preparing a PI3K inhibitor
9. 10336759 - Salts and processes of preparing a PI3K inhibitor
10. 10280157 - Process for the synthesis of an indoleamine 2,3-dioxygenase inhibitor
11. 9908888 - Processes for preparing pyrazolyl-substituted pyrrolo[2,3-d]pyrimidines
12. 9873688 - Process for the synthesis of an indoleamine 2,3-dioxygenase inhibitor
13. 9321755 - Process for the synthesis of an indoleamine 2,3-dioxygenase inhibitor
14. 9290506 - Processes for preparing JAK inhibitors and related intermediate compounds
15. 9067921 - Piperazinylpiperidine derivatives as chemokine receptor antagonists